DCF — BELLEVUE HOSPITAL CENTER
Enterprise Value: $-3.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.5B
Enterprise Value
$-1.1B
PV of Cash Flows
$-2.4B
PV of Terminal Value
$-3.9B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.3B | $-230.3M | -17.0% | $-287.4M | $-261.3M |
| Year 2 | $1.4B | $-223.3M | -16.0% | $-282.1M | $-233.2M |
| Year 3 | $1.4B | $-215.7M | -15.0% | $-276.3M | $-207.6M |
| Year 4 | $1.5B | $-214.9M | -15.0% | $-277.2M | $-189.3M |
| Year 5 | $1.5B | $-217.5M | -14.0% | $-281.7M | $-174.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.3B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17586258808628005
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5